HK Stock Market Move | PCB concept stocks all plummet, Huang Renxun denies Rubin Ultra delay rumors, institutions point out AI hardware overcrowding situation is slightly easing.
Conceptual stocks related to PCB all plummeted, as of the time of writing, Geotest Group (00148) dropped by 15.85%, to 61.85 Hong Kong dollars; Geotest Multilayer Board (01888) fell by 14.65%, to 53.6 Hong Kong dollars; Grand Innovation Group (03200) declined by 12.34%, to 120.1 Hong Kong dollars; and Guanghe Technology (01989) dropped by 4.78%, to 129.5 Hong Kong dollars.
PCB concept stocks across the board plummeted, as of the time of writing, KINGBOARD HLDG (00148) fell 15.85% to HK$61.85; KB LAMINATES (01888) fell 14.65% to HK$53.6; Shenzhen Hans CNC Technology (03200) fell 12.34% to HK$120.1; DELTON (01989) fell 4.78% to HK$129.5.
On the news front, rumors in the market suggest that Rubin Ultra may be delayed until 2028. On July 11th local time, Morgan Stanley released a summary of a non-deal roadshow with NVIDIA management. NVIDIA CEO Huang Renxun, along with CFO Colette Kress and other executives, attended and communicated with institutional investors, stating that the company's quarterly revenue is approaching $100 billion, with growth still on the rise, and denied rumors of a Rubin Ultra delay, confirming that it will be shipped next year as planned.
Guolianan Fund stated that this round of overseas market sell-off originated from a loosening of crowding in the AI hardware race track, with concerns in the market that the previous AI speculation was overly exuberant, leading to a collective opening of risk reduction positions by funds. In the first half of the year, semiconductor, AI computing power, optical module, and other core race tracks showed strong performance, with many popular assets experiencing significant gains so far this year, accumulating a large amount of unrealized profits for the sector as a whole, with short-term reversal risks continuing to accumulate. The adjustment started with the most popular assets with the highest gains so far this year, showing clear characteristics of profit-taking.
Related Articles

TASTEGOURMET GP (08371) plans to open a new Kin Long Teppanyaki restaurant in Hong Kong.

ANTENGENE-B (06996) received a $60 million upfront payment from UCB for ATG-201.

SSY GROUP (02005): Mabalocevir has been approved by the National Medical Products Administration for registration as an active pharmaceutical ingredient for use in marketed formulations.
TASTEGOURMET GP (08371) plans to open a new Kin Long Teppanyaki restaurant in Hong Kong.

ANTENGENE-B (06996) received a $60 million upfront payment from UCB for ATG-201.

SSY GROUP (02005): Mabalocevir has been approved by the National Medical Products Administration for registration as an active pharmaceutical ingredient for use in marketed formulations.

RECOMMEND





